Latest News - Waters Corporation
Top Corporates Hub
Waters Corporation
Waters (WAT): Exploring Valuation Potential Following Recent Share Price Dip
08.10.2025 09:11
Waters (WAT) shares have caught some attention lately, especially after a dip of nearly 3% in the latest trading session. With investors evaluating what is next for this life sciences giant, recent stock moves may offer fresh entry points. See our latest analysis for Waters. Over the past year, Waters’ share price return has been notably soft, with momentum fading after a strong run in previous years. Despite a recent 6% bounce over the last week, its year-to-date share price return stands at...
3 Reasons to Sell WAT and 1 Stock to Buy Instead
08.10.2025 04:04
Waters Corporation has been treading water for the past six months, recording a small return of 3.5% while holding steady at $318.35. The stock also fell short of the S&P 500’s 34.7% gain during that period.
Waters Merger Risks Weakening Its Competitive Moat
29.09.2025 05:28
Waters' merger with Becton, Dickinson and Companyâs Bioscience and Diagnostic Solutions business is a strategic move. Read why WAT stock is a Hold.
Waters Corporation (WAT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
04.09.2025 11:59
Waters Corporation discusses strong quarterly growth, strategic BD acquisition, and
Waters Corp (WAT) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Raised Guidance
05.08.2025 07:09
Waters Corp (WAT) reports robust Q2 performance with 9% sales growth and raises full-year guidance, despite challenges in certain segments.
Waters (WAT) Surpasses Q2 Earnings and Revenue Estimates
04.08.2025 11:10
Waters (WAT) delivered earnings and revenue surprises of +0.68% and +3.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Waters Corporation 2025 Q2 - Results - Earnings Call Presentation
04.08.2025 11:06
The following slide deck was published by Waters Corporation in conjunction with their 2025 Q2 earnings call.
Waters Corporation (WAT) Q2 2025 Earnings Call Transcript
04.08.2025 11:05
Waters Corporation (NYSE:WAT) Q2 2025 Earnings Conference Call August 4, 2025 8:00 AM ETCompany ParticipantsAmol Chaubal - Senior VP & CFOCaspar Tudor -...
Waters Corporation (NYSE:WAT) Posts Better-Than-Expected Sales In Q2, Quarterly Revenue Guidance Slightly Exceeds Expectations
04.08.2025 10:15
Scientific instruments company Waters Corporation (NYSE:WAT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.9% year on year to $771.3 million. Guidance for next quarter’s revenue was better than expected at $781 million at the midpoint, 0.7% above analysts’ estimates. Its non-GAAP profit of $2.95 per share was in line with analysts’ consensus estimates.
Waters: Q2 Earnings Snapshot
04.08.2025 10:11
The results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $2.93 per share. The maker of products used in drug discovery and development posted revenue of $771.3 million in the period, which also topped Street forecasts.
Waters Corporation (NYSE: WAT) Reports Second Quarter 2025 Financial Results
04.08.2025 10:00
Waters Corporation (NYSE: WAT), today announced its financial results for the second quarter of 2025.
Why Waters (WAT) is a Top Growth Stock for the Long-Term
01.08.2025 13:45
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
iRadimed (IRMD) Q2 Earnings and Revenues Surpass Estimates
01.08.2025 13:45
iRadimed (IRMD) delivered earnings and revenue surprises of +8.89% and +0.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BD Biosciences & Diagnostic Solutions and Waters to merge in $17.5bn deal
15.07.2025 10:56
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026.
Becton, Dickinson and Company: A Solid Divestment For Its Bioscience And Diagnostics Business
15.07.2025 07:28
Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A and why I remain bullish on BDX.
Top Midday Stories: Musk Doesn't Support Tesla-xAI Merger; Huntington to Buy Veritex for $1.9 Billion
14.07.2025 15:37
The S&P 500, Dow Jones and Nasdaq Composite were up slightly in late-morning trading Monday as Presi